Cargando...
The case for dosing dabigatran: how tailoring dose to patient renal function, weight and age could improve the benefit–risk ratio
Dabigatran is increasingly being used in clinical practice for the thromboprophylaxis in atrial fibrillation as a convenient therapy that needs no drug level monitoring. However, analysis of the data of the same clinical trial that led to the adoption of dabigatran in fixed-dosing regimens has indic...
Guardado en:
| Publicado en: | Ther Adv Neurol Disord |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4643866/ https://ncbi.nlm.nih.gov/pubmed/26600870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285615601360 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|